Color vision deficiency (CVD) is a defect of vision with disability to distinguish colors. Color vision deficiency can be divided into the two categories, congenital and acquired. Congenital color vision deficiency divided into anomalous trichromacy, dichromacy and monochromacy. The most common congenital CVD was deuteranomalous that mode of inheritance is X linked recessive occurring mostly in males. Acquired CVD can occur as a direct result of illness or any related medicine. Color perception changes in acquired CVD may be secondary to primary ocular disease, drug side effect, or serious systemic disease such as diabetes. Dystrophy of cone, types of maculopathy, crystalline lens changes associated with aging, diabetes, glaucoma, optic nerve diseases and traumatic brain injuries can cause CVD. For acquired CVD, type of defect may not be easy to classify; nevertheless, predominantly is tritanopia and type and severity of the defect fluctuates during of disease. It has been suggested that human evolution to industrialized civilization has led to an increased prevalence of CVD in most population. An acquired CVD can reflect a deficiency in color information processing at anywhere along the related visual pathway, from the photoreceptors to the cortex. Sometimes, assessment of color vision can be helpful to detect a visual impairment in early stages.

Background and Objective: Evaluating the agreement among various corneal imaging devices is crucial due to their varying technologies in diagnosing corneal parameters. This study aimed to assess the agreement of Advanced Corneal Explorer (ACE) with Pentacam and Orbscan in myopic individuals with healthy corneas.
Methods: This descriptive-analytical study was conducted on 45 myopic individuals (25 women and 20 men; mean age=30.37±6.13 years) referring to Al-Zahra Ophthalmology Hospital in Zahedan, Iran, during 2023. Anterior segment imaging was performed using three devices: ACE, Pentacam, and Orbscan. Corneal parameters, including topography, tomography, and corneal aberrations, were examined. The intraclass correlation coefficient (ICC) and 95% limits of agreement (LoA) were used to evaluate the agreement of ACE data with the data obtained from the other two devices.
Results: ACE exhibited good agreement with Pentacam for the mean power (ICC=0.97), maximum power (ICC=0.98), and minimum power of the anterior corneal surface (ICC=0.97) (P<0.05). Additionally, ACE exhibited good statistical agreement with Orbscan for the mean power of the anterior corneal surface due to an ICC of 0.98 (P<0.05). The ICC values for central corneal thickness and thinnest corneal thickness with the ACE and Pentacam devices were 0.99 and 0.95, respectively, indicating significant statistical agreement (P<0.05). White-to-white distance, pupil size, and corneal aberrations did not show good agreement among the three devices (ICC<0.75).
Conclusion: Topography values and corneal thickness measured with ACE showed good agreement with Pentacam; therefore, they can be used interchangeably. Other measured variables from ACE did not show good agreement with Pentacam and Orbscan and are not interchangeable.